Google accuses Microsoft, Apple of patent conspiracy
Los Angeles/ San Francisco : Google Inc, fresh off losing a bid to buy thousands of valuable patents from bankrupt Nortel, accused its biggest rivals on Wednesday of banding together to block the...
View ArticlePatent wars: How Microsoft and Apple are taking it to Android
With their massive patent hoard, the current incumbents in the smartphone and tablet market especially can bleed dry any company whose devices being to threaten their market share...
View ArticleBritish telecom firm BT sues Google over patent infringement
The BT claim relates to six patents which BT says are infringed by Google's highly successful mobile platform Android, Google Maps, Google Music, advertising services, gmail and other products.
View ArticleFacebook prepares for Yahoo battle, buys 750 IBM patents
Facebook has acquired patents from IBM as it girds itself for litigation, including a lawsuit by Yahoo.
View ArticleUS names and shames India, puts it on piracy watch list
India finds dishonourable mention as a hotbed of piracy in a US report on intellectual property, which targets the world’s worst offenders.
View ArticleDid Cipla breach patent rights by slashing cancer drug price?
German pharma major Bayer has charged that Cipla had breached its patent rights by slashing the price of a generic version of its patent-protected cancer drug Nexavar last week.
View ArticleFacebook, Yahoo forge partnership, settle patent lawsuits
Facebook and Yahoo agreed to forge a broad Internet advertising and licensing partnership, laying to rest their dueling patent lawsuits.
View ArticleUK lifts Samsung ban as its not as ‘cool’ as Apple
Samsung Electronics defeated Apple in the latest spat in the rivals' patent wars when a British judge ruled Samsung's Galaxy tablets did not infringe the US company's designs for the iPad because they...
View ArticleiPhone killer? Samsung Galaxy S III already at 10 million mark
If Apple is worried, it's with good reason. The Samsung Galaxy S III has surpassed even the companies own expectations, crossing the ten million sales mark two weeks earlier than even Samsung predicted!
View ArticleApple submits ‘purple prototype’ to prove it didn’t copy Sony
Apple has reportedly submitted documents revealing the prototype of a 'purple' phone to counter Samsung's allegations that it copied the design for the iPhone from Sony.
View ArticleUS allows Kodak to sell key patent
Eastman Kodak Co can proceed with the sale of a key digital imaging patent, a bankruptcy judge ruled on Wednesday, saying that Apple Inc waited too long to raise a claim of infringement.
View ArticleSamsung begins defence: attacks ‘crazy’ Apple patents
Samsung has now begun to present it own side of the evidence in the trial and it seems that the South-Korean giant is going for the offense and has challenged two of Apple's key patents:...
View ArticleIndia revokes Roche patent; questions high price of drug
The Intellectual Property Appellate Board (IPAB) cited a lack of evidence that the drug was any better than existing treatments and its high price as reasons for the decision.
View ArticleMobile war: Nokia wins patent ruling against RIM
The Swedish arbitrator ruled RIM was not entitled to make or sell mobile devices which can hook up to WiFi networks - using technology known in the trade as WLAN or wireless local access network...
View ArticleBoost for cheaper drugs: SC rejects Novartis patent on Glivec
A decision in the seven-year legal battle is keenly awaited by the two most interested parties— big pharma companies and health aid groups — with both sides saying the outcome will set a precedent with...
View ArticleMerck unit sues Glenmark for infringing patent on diabetes drug
Merck's Indian unit, MSD, holds an Indian patent on sitagliptin, a chemical compound sold under the Januvia and Janumet brands.
View ArticleNovartis patent row: US ‘concerned’ over India’s patent...
Raising questions over innovation climate in India, the US has said the recent decision by India's Supreme Court to prohibit patent of Novartis' cancer drug Glivec could "preclude issuance of a patent"...
View ArticleTeva, Sun Pharma to pay $2.15 bn to settle Pfizer patent suit for acid-reflux...
This is the first instance of generic drugmakers paying damages for marketing a copy of an existing drug for which patents have yet to expire - known as an 'at-risk' launch.
View ArticleNot just India: UK regulator says Roche’s new breast cancer drug too costly
The National Institute for Care and Excellence (NICE) of the UK has rejected Roche’s latest breast cancer drug Perjeta because it is too expensive.
View ArticleJury decides in favour of Microsoft in patent trial against Google’s Motorola
Microsoft Corp said on Wednesday a jury decided in its favor in the second of two trials in federal court in Seattle concerning Motorola's licensing of so-called standard, essential patents used in...
View Article
More Pages to Explore .....